1. Home
  2. CNTA vs SEMR Comparison

CNTA vs SEMR Comparison

Compare CNTA & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • SEMR
  • Stock Information
  • Founded
  • CNTA 2020
  • SEMR 2008
  • Country
  • CNTA United Kingdom
  • SEMR United States
  • Employees
  • CNTA N/A
  • SEMR N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • SEMR EDP Services
  • Sector
  • CNTA Health Care
  • SEMR Technology
  • Exchange
  • CNTA Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • CNTA 1.6B
  • SEMR 1.5B
  • IPO Year
  • CNTA 2021
  • SEMR 2021
  • Fundamental
  • Price
  • CNTA $13.51
  • SEMR $9.84
  • Analyst Decision
  • CNTA Strong Buy
  • SEMR Buy
  • Analyst Count
  • CNTA 11
  • SEMR 8
  • Target Price
  • CNTA $27.00
  • SEMR $17.00
  • AVG Volume (30 Days)
  • CNTA 730.3K
  • SEMR 721.7K
  • Earning Date
  • CNTA 05-14-2025
  • SEMR 05-07-2025
  • Dividend Yield
  • CNTA N/A
  • SEMR N/A
  • EPS Growth
  • CNTA N/A
  • SEMR N/A
  • EPS
  • CNTA N/A
  • SEMR 0.05
  • Revenue
  • CNTA $15,000,000.00
  • SEMR $396,021,000.00
  • Revenue This Year
  • CNTA N/A
  • SEMR $21.80
  • Revenue Next Year
  • CNTA N/A
  • SEMR $18.15
  • P/E Ratio
  • CNTA N/A
  • SEMR $207.55
  • Revenue Growth
  • CNTA 118.88
  • SEMR 22.75
  • 52 Week Low
  • CNTA $7.90
  • SEMR $7.90
  • 52 Week High
  • CNTA $19.09
  • SEMR $18.74
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 56.37
  • SEMR 44.62
  • Support Level
  • CNTA $12.11
  • SEMR $9.54
  • Resistance Level
  • CNTA $13.23
  • SEMR $10.16
  • Average True Range (ATR)
  • CNTA 0.73
  • SEMR 0.37
  • MACD
  • CNTA 0.12
  • SEMR -0.10
  • Stochastic Oscillator
  • CNTA 98.13
  • SEMR 18.44

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

Share on Social Networks: